Therapieoptionen der weiblichen Belastungsharninkontinenz

Zusammenfassung

Die Belastungsharninkontinenz der Frau ist gekennzeichnet durch Urinverluste bei körperlicher Belastung ohne damit einhergehenden Harndrang. Die Ursachen sind mannigfaltig und bedürfen einer guten Kenntnis der Beckenbodenstrukturen und Funktionalität des Verschlussapparates der Harnblase. Vor einer Therapie muss differenzierte Diagnostik die Ursachen aufdecken, um den betroffenen Frauen die idealen therapeutischen Optionen aufzeigen zu können. Neben konservativen Therapiestrategien stehen heute mehrere operative Alternativen zur Verfügung, die je nach funktionellem und/oder anatomischen Defizit zur Anwendung kommen können. Die Ergebnisse der operativen Korrekturen sind gut, auch wenn eine geringe Rate an möglichen Komplikationen in Kauf genommen werden muss.

Abstract

Stress urinary incontinence in female patients is characterised by loss of urine without the need to urinate. Causes are manifold and require a good knowledge of the pelvic floor structures and the functionality of the bladder's occlusion system. Before any treatment can be initiated, differentiated diagnostic investigation must uncover the causes in order to be able to show incontinent women the ideal therapeutic options. In addition to conservative treatment strategies, there are several surgical alternatives available that can be used depending on the functional and/or anatomical deficit. Surgical correction produces good results, although a minor rate of possible complications must be accepted.

Schlüsselwörter

Belastungsharninkontinenz - Spannungsfreie suburethrale Schlingen - Kolposuspension - Artifizieller Spinkter

Keywords

stress urinary incontinence - colposuspension - artificial sphincter - tension-free vaginal tape

Publikationsverlauf

Artikel online veröffentlicht:
19. April 2021

• Referenzen

• 1 Abrams P, Cardozo L, Fall M. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-782
• 2 https://www.awmf.org/uploads/tx_szleitlinien/015_005l_S2e_Belastungsinkontinenz_2013-07-abgelaufen.pdf
• 3 Imamura M, Abrams P, Bain C. et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 2010; 14: 1-188
• 4 Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn 2008; 27: 749-757
• 5 Cody JD, Jacobs ML, Richardson K. et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2012;
• 6 Lucas MG, Bosch RJL, Burkhard FC. et al. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. Eur Urol 2012; 62: 1130-1142
• 7 https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mammakarzinom_4_0/Version_4.4/LL_Mammakarzinom_Langversion_4.04.pdf
• 8 Aktories K, Förstermann U, Hofmann FB. et al. Allgemeine und spezielle Pharmakologie und Toxikologie. 9. Auflage. München: Elsevier GmbH, Urban & Fischer Verlag; 2005
• 9 Crandall CJ, Kathleen M, Hovey KM. et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 2018; 25: 11-20
• 10 Rueda C, Osorio AM, Avellaneda AC. et al. The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Climacteric 2017; 20: 321-330
• 11 Paton DM. Estradiol vaginal inserts (Imvexxy). effective in genitourinary syndrome of menopause without increasing systemic estrogen levels. Drugs Today (Barc) 2018; 54: 667-677
• 12 Sussman TA, Kruse ML, Thacker HL. et al. Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy. J Oncol Pract 2019; 15: 363-370
• 13 The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020; 27: 976-992
• 14 Rajaofetra N, Passagia JG, Marlier L. et al. Serotoninergic, noradrenergic, and peptidergic innervation of Onuf’s nucleus of normal and transected spinal cords of baboons (Papio papio). J Comp Neurol 1992; 318: 1-17
• 15 Morrison J, Steers WD, Brading A. et al. In: Abrams P, Cardozo L, Khoury S. et al. (Hrsg.) Incontinence, 2nd edn. Plymouth: Plymbridge Distributors Ltd; 2002: 83-163
• 16 Mariappan P, Alhasso A, Ballantyne Z. et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 2007; 51: 67-74
• 17 Shamliyan TA, Kane RL, Wyman J. et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148: 459-473
• 18 Li J, Yang L, Pu C. et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol 2013; 45: 679-686
• 19 Lenzer J. FDA warns that antidepressants may increase suicidality in adults. BMJ 2005; 331: 70
• 20 Hay-Smith J, Morkved S, Fairbrother KA. et al. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2008;
• 21 Haddow G, Watts R, Robertson J. Effectiveness of a pelvic floor muscle exercise program on urinary incontinence following childbirth. International journal of evidence- based healthcare 2005; 3: 103-146
• 22 Wagg A, Bunn F. Unassisted pelvic floor exercises for postnatal women: a systematic review. Journal of advanced nursing 2007; 58: 407-417
• 23 Szumilewcz A, Kuchta A, Monika Kranich M. et al. Prenatal high-low impact exercise program supported by pelvic floor muscle education and training decreases the life impact of postnatal urinary incontinence: A quasiexperimental trial. Medicine (Baltimore) 2020;
• 24 Felicissimo MF, Carneiro MM, Saleme CS. et al. Intensive supervised versus unsupervised pelvic floor muscle training for the treatment of stress urinary incontinence: a randomized comparative trial. International urogynecology journal 2010; 21: 835-840
• 25 Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev 2011;
• 26 Berghmans LC, Hendriks HJ, Bo K. et al. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 1998; 82: 181-191
• 27 Bo K, Finckenhagen HB. Vaginal palpation of pelvic floor muscle strength: inter-test reproducibility and comparison between palpation and vaginal squeeze pressure. Acta Obstet Gynecol Scand 2001; 80: 883-887
• 28 Lo SK, Naidu J, Cao Y. Additive effect of interferential therapy over pelvic poor exercise alone in the treatment of femele urinary stress and urge incontinence: a randomized controlled trial. Hong Kong Physiotherapy Journal 2003; 21: 37-42
• 29 Sherburn M, Bird M, Carey M. et al. Incontinence improves in older women after intensive pelvic floor muscle training: an assessor-blinded randomized controlled trial. Neurourol Urodyn 2011; 30: 317-324
• 30 Hui E, Lee PS, Woo J. Management of urinary incontinence in older women using videoconferencing versus conventional management: a randomized controlled trial. Journal of telemedicine and telecare 2006; 12: 343-347
• 31 Parker WP, Griebling TL. Nonsurgical Treatment of Urinary Incontinence in Elderly Women. Clin Geriatr Med 2015; 31: 471-485
• 32 Bø K, Herbert RD. There is not yet strong evidence that exercise regimens other than pelvic floor muscle training can reduce stress urinary incontinence in women: a systematic review. Physiother 2013; 59: 159-168
• 33 Nager CW, Richter HE, Nygaard I. et al. Incontinence pessaries: size, POPQ measures, and successful fitting. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 1023-1028
• 34 Richter HE, Burgio KL, Brubaker L. et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 2010; 115: 609-617
• 35 Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev 2011;
• 36 Lapii GA. et al. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med 2017; 162: 510-514
• 37 Digesu GA, Swift S. Laser treatment in urogynaecology and the myth of the scientific evidence. Int Urogynecol J 2017; 28: 1443-1444
• 38 Franić D, Fistonić I. Laser Therapy in the Treatment of Female Urinary Incontinence and Genitourinary Syndrome of Menopause: An Update. Biomed Res Int 2019; 2019: 1576359
• 39 Mackova K, Van Daele L, Page A-S. et al. Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG 2020; 127: 1338-1346
• 40 Gonzalez Isaza P. et al. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J 2018; 29: 211-215
• 41 Gunnemann A, Liedl B, Goeschen K. 25 Jahre Inegraltheorie nach Petros. Was bleibt? Was kommt?. Urologe 2017; 56: 1548-1558
• 42 Petros P, Ulmsten U. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand 1990; 69: 7-51
• 43 Kirchin V, Page T, Keegan PE. et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2012;
• 44 Hegele A, Varga Z, Hofmann R. et al. Therapie der weiblichen Harninkontinenz. In: Michel MS, Thürhoff JW, Janetschek G. et al. (Hrsg.) Die Urologie, Band 1, 1. Auflage. Springer Verlag; 2016: 905-940
• 45 Ulmsten U, Falconer C, Johnson P. et al. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1998; 9: 210-213
• 46 Panagiotis B, Emmanouel P, Charalampos K. et al. Assessment of the long-term outcome of TVT procedure for stress urinary incontinence in a female population: results at 17 years' follow-up. Int Urogynecol J 2019; 30: 265-269
• 47 Braga A, Caccia G, Sorice P. et al. Tension-free vaginal tape for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 17-year follow-up. BJU Int 2018; 122: 113-117
• 48 Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol 2001; 11: 1306-1313
• 49 Petri E, Ashok K. Comparison of late complications of retropubic and transobturator slings in stress urinary incontinence. Int Urogynecol J 2012; 23: 321-325
• 50 Abdel-Fattah M, Ford JA, Lim CP. et al. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur Urol 2011; 60: 468-480
• 51 Nambiar A, Cody JD, Stephen TJ. et al. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev 2017; 7: CD008709
• 52 Burch JC. Urethrovaginal fixation to Cooper's ligament for correction of stress incontinence, cystocele, and prolapse. Am J Obstet Gynecol 1961; 81: 281-290
• 53 Veit-Rubin N. et al. Burch colposuspension. Neurourol Urodyn 2019; 38: 553-562
• 54 Lapitan MCM, Cody JD, Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2017; 7: CD002912
• 55 Alcalay M, Monga A, Stanton SL. Burch colposuspension: a 10–20 year follow up. Br J Obstet Gynaecol 1995; 102: 740-745
• 56 Dean N, Ellis G, Herbison GP. et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2017; 7: Cd002239
• 57 Ogah J, Cody DJ, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women: a short version Cochrane review. Neurourol Urodyn 2011; 30: 284-291
• 58 Novara G, Artibani W, Barber MD. et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 2010; 58: 218-238
• 59 Lucas MG, Bosch JLHR, Cruz FR. et al. Guidelines on Urinary Incontinence. European Association of Urology (EAU); 2012 http://www.uroweb.org
• 60 Lucas MG, Bosch JLHR, Cruz FR. et al. Guidelines on Urinary Incontinence. European Association of Urology (EAU); 2012 http://www.uroweb.org
• 61 Sarver R, Govier FE. Pubovaginal slings: past, present and future. Int Urogynecol J Pelvvic floor Dysfunct 1997; 8: 358-368
• 62 Phe V, Roupret M, Mozer P. et al. Trends in the landscape of artificial urinary sphincter in men and women in France over the past decade. Eur Urol 2013; 63: 404-412
• 63 Costa P, Poinas G, Naoum KB. et al. Long-term results of articial urinary sphinkter for womenwith type III stress urinary incontinence. Eur Urol 2013; 63: 753-758
• 64 Mandron E, Bryckaert P-E, Papatsoris AG. Laparoscopic artificial urinary sphinkter implantation for female genuine stress urinary incontinence: technique and 4-year experience in 25 patients, Journal Complicaton. BJU Int 2010; 106: 1194-1198
• 65 Reisenauer C, Muche-Borowski C, Anthuber C. et al. Interdisziplinäre S2e-Leitlinie für die Diagnostik und Therapie der Belastungsharninkontinenz der Frau. AWMF-Online-register Nr. 015/005.
• 66 Sperling H, Kaufmann A, Bonn I. et al. Artifizieller Schließmuskel bei der Frau – zu selten?. Urologe 2017; 56: 1572-1575
• 67 Peyronnet B, Belas O, Capon G. et al. Roboterassisted articial urinary sphinkter implantation in female patients: a multicenter study. Eur Urol 2017; 16: 1496